Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Completed · Phase 3 · Has a placebo group

Conditions studied: Metrorrhagia

In brief

The purpose of this study is to determine whether the study drug is safe and effective in the treatment of dysfunctional uterine bleeding.

Key facts

Study ID
NCT00293059
Run by
Bayer
People needed
190
Starts
2005-12-01
Expected to finish
2008-05-01
Last updated by the study team
2013-11-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.